Alder Matthias 4
4 · Gain Therapeutics, Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-03-26+18,750→ 25,763 total - Exercise/Conversion
Common Stock
2024-03-26+825→ 26,588 total - Exercise/Conversion
Common Stock
2024-03-26+637→ 27,225 total - Tax Payment
Common Stock
2024-03-26$4.06/sh−6,085$24,705→ 21,140 total - Exercise/Conversion
Restricted Stock Units
2024-03-26−825→ 8,250 total→ Common Stock (249 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-26−637→ 6,376 total→ Common Stock (192 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-26−18,750→ 56,250 total→ Common Stock (18,750 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F4]The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.